Company Registration No. 12517848 (England and Wales)
Diabetes And Endocrine Health Ltd
Unaudited accounts
for the year ended 31 March 2025
Diabetes And Endocrine Health Ltd
Unaudited accounts
Contents
Diabetes And Endocrine Health Ltd
Company Information
for the year ended 31 March 2025
Director
Dr Dulmini Kokilari Kathyana Kariyawasam
Company Number
12517848 (England and Wales)
Registered Office
131 South End
C/O Aczone Consultants Ltd
Croydon
CR0 1BJ
United Kingdom
Diabetes And Endocrine Health Ltd
Statement of financial position
as at 31 March 2025
Tangible assets
23,129
29,242
Investments
155,000
10,000
Cash at bank and in hand
23,164
118,978
Creditors: amounts falling due within one year
(74,549)
(69,582)
Net current (liabilities)/assets
(21,385)
49,396
Total assets less current liabilities
156,744
88,638
Creditors: amounts falling due after more than one year
(5,918)
(5,918)
Called up share capital
100
100
Profit and loss account
150,726
82,620
Shareholders' funds
150,826
82,720
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 25 September 2025 and were signed on its behalf by
Dr Dulmini Kokilari Kathyana Kariyawasam
Director
Company Registration No. 12517848
Diabetes And Endocrine Health Ltd
Notes to the Accounts
for the year ended 31 March 2025
Diabetes And Endocrine Health Ltd is a private company, limited by shares, registered in England and Wales, registration number 12517848. The registered office is 131 South End, C/O Aczone Consultants Ltd, Croydon, CR0 1BJ, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
4
Tangible fixed assets
Motor vehicles
Computer equipment
Total
Cost or valuation
At cost
At cost
At 1 April 2024
49,590
3,480
53,070
At 31 March 2025
49,590
5,078
54,668
At 1 April 2024
21,697
2,131
23,828
Charge for the year
6,974
737
7,711
At 31 March 2025
28,671
2,868
31,539
At 31 March 2025
20,919
2,210
23,129
At 31 March 2024
27,893
1,349
29,242
5
Investments
Other investments
Valuation at 1 April 2024
10,000
Valuation at 31 March 2025
155,000
Diabetes And Endocrine Health Ltd
Notes to the Accounts
for the year ended 31 March 2025
Amounts falling due after more than one year
7
Creditors: amounts falling due within one year
2025
2024
Bank loans and overdrafts
10,356
16,274
Taxes and social security
24,764
15,797
Loans from directors
36,766
36,009
8
Creditors: amounts falling due after more than one year
2025
2024
9
Average number of employees
During the year the average number of employees was 1 (2024: 1).